News

Info

Global Patent Protection Under the PCT System

November 22, 2020

Glucosenz is currently filing for PCT in Australia, with the assistance of Pintas IP, our strategic partner specialising in the creation, protection and globalisation of intellectual property rights in ASEAN countries and beyond.

Read This Post
News

Insights on Glucosenz Features during Digital Health Innovations Webinar

November 2, 2020

Glucosenz hosted a Digital Health Innovations Webinar with some 50 attendees from Malaysia and four other countries. The webinar discussed the importance of Glucosenz in the medical world.

Read This Post
Event

Glucosenz Digital Global Fundraise Campaign

October 19, 2020

Blood glucose monitoring will no longer be associated with pain, but instead a painless, seamless and non-invasive technology with Glucosenz. Joining us in this live webinar are three renowned speakers with years of experience in their respective industries.

Read This Post
Info

Road Towards Commercialisation

October 18, 2020

Commercialisation is in sight for Glucosenz as it prepares for final submission to the Medical Device Authority (MDA), as well as the application for ISO 13485 standard and CE Marking—certifications that are needed for Glucosenz to be marketed as a medical device.

Read This Post

Glucosenz User Experience Roadshow

October 13, 2020

Since August, Glucosenz has conducted Glucosenz User Experience Roadshows at several strategic locations to introduce the Glucosenz technology to the public as well as to gather qualitative feedback from users.

Read This Post
Health

COVID-19 and Diabetes: A New Health Challenge

October 10, 2020

A study by University of Nantes finds that the mortality rate of diabetics hospitalised with COVID-19 are higher than non-diabetics, with 10% of diabetics losing their lives within seven days of hospitalisation.

Read This Post